GW plans cannabis offshoots


GW plans cannabis offshoots

Sativex, launched in the UK in June, is the only cannabis-based medicine to receive approval from medical authorities for use as a prescription drug, and has been the driving force behind Aim-traded GW. However, Justin Gover, managing director, ...

Top stories of the last 30 days